Market Overview

Monarch Medical Technologies Expands Medical Advisory Board with Addition of Diabetes Experts


Dr. Carlos Mendez & Dr. Brian Ulmer Join Roster of Medical Experts to
Support Company in Delivering Individualized Insulin Dosing for Improved
Inpatient Diabetes Management

Medical Technologies
, the leader in precision insulin dosing for
optimized inpatient glucose management, today announced the appointments
of Carlos Mendez, MD, FACP and Brian Ulmer, MD, CDE to Monarch's Medical
Advisory Board. The board serves to advise Monarch in the continual
advancement of their services and solution, the EndoTool Glucose
Management System, a Class II FDA-cleared, software suite, providing
personalized dosing recommendations for intravenous and subcutaneous
insulin therapy.

"We are pleased to welcome Dr. Mendez and Dr. Ulmer to our Medical
Advisory Board," said Laurel Fuqua, Executive Vice President and Chief
Clinical Officer of Monarch Medical Technologies. "As recognized
diabetes leaders with a wealth of experience as healthcare professionals
and researchers, we are confident they will be invaluable as we continue
to advance our predictive insulin dosing technology and glycemic
management services in the ever-evolving and expanding market of
glycemic management."

Dr. Mendez currently serves as an Associate Professor of Medicine
specializing in diabetes management within the Divisions of General
Internal Medicine, and Endocrinology, Diabetes, and Metabolism at the
Froedtert/Medical College of Wisconsin and is the Director of the
Diabetes Program at the Clement Zablocki Veterans Affairs Medical
Center. Prior to this role, he was the Director of the Diabetes
Management Program at the Veterans Affairs Medical Center in Albany, NY
for six years. Dr. Mendez, who is originally from Venezuela, obtained
his medical degree from the Universidad de Carabobo. He then proceeded
to complete his residency in Internal Medicine at the John Stroger
Hospital of Cook County in Chicago, IL and his Fellowship in Diabetes at
the East Carolina University in Greenville, North Carolina.

Dr. Mendez has been deeply involved in academic research with multiple
peer review publications and book chapters, and frequently presents
lectures nationally and internationally on the management of
diabetes. He is also involved in multiple organizational and leadership
committees. He serves as the Associate Chair for the National Diabetes
Field Advisory Committee for the Veterans Health Administration as well
as the President for the American Diabetes Association Wisconsin
Community Leadership Board.

"As clinical research has made clear, achieving glucose targets is
associated with improved patient outcomes, shorter length of stay, and
ultimately a reduction in the cost of care," said Dr. Mendez.
"Optimizing glycemic management should be a priority for hospitals, and
I'm thrilled to join Monarch's Medical Advisory Board to shed light on
the importance of glycemic management within the inpatient setting and
guide the company in offering a solution and services that can aid
hospitals in improving the safety of their insulin dosing."

Dr. Ulmer is a Diabetologist at St. Vincent Medical Group in
Indianapolis, IN, where he serves on the Glycemic Action Committee and
is the diabetes lead of the remote care monitoring program. Previously,
Dr. Ulmer led an inpatient diabetes management team at Indiana
University Health-Methodist Hospital in Indianapolis. He obtained a
bachelor's degree from the University of Notre Dame and completed his
medical degree and residency at the Indiana University School of
Medicine. Dr. Ulmer frequently lectures on inpatient glycemic
management, and his clinical research interests include the safe use of
insulin during hospitalization.

"Having lived with type 1 diabetes since a young age, I realize the
challenges faced with inpatient insulin dosing and have dedicated my
career to keeping patients safe during hospitalization," said Dr. Ulmer.
"I am honored to be involved with a company that is truly improving the
standard of diabetes care while achieving excellent clinical outcomes.
Monarch's EndoTool products support physicians, nurses and hospital
diabetes educators in caring for their patients while significantly
lowering rates of hypoglycemia."

To learn more about Monarch Medical Technologies, please contact

About Monarch Medical Technologies

Monarch Medical Technologies is the leading provider of electronic
systems for inpatient glycemic management. Monarch's EndoTool® Glucose
Management System offers personalized dosing recommendations for
intravenous and subcutaneous insulin therapy. As a Class II FDA-cleared,
patent pending software suite, EndoTool has enabled more than 235
hospitals to provide unsurpassed patient-specific glycemic control
across a broad population of patients, and ultimately deliver better,
safer care. For more information, please visit

View Comments and Join the Discussion!